Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Joseph H Wender. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Joseph H Wender har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:IONS / Ionis Pharmaceuticals, Inc. | Director | 108 835 |
US:OUT / OUTFRONT Media Inc. | Director | 69 996 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Joseph H Wender. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i IONS / Ionis Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i IONS / Ionis Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Joseph H Wender som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 200 | 108 835 | −9,33 | 60,14 | −673 549 | 6 545 152 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 600 | 120 035 | −4,46 | 57,53 | −322 174 | 6 905 746 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 200 | 125 635 | −8,19 | 55,04 | −616 432 | 6 914 775 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 200 | 108 835 | −9,33 | 60,14 | −673 549 | 6 545 152 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 600 | 120 035 | −4,46 | 57,53 | −322 174 | 6 905 746 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 200 | 125 635 | −8,19 | 55,04 | −616 432 | 6 914 775 |
2025-07-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 079 | 136 835 | 3,07 | ||||
2025-06-05 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 771 | 69 996 | 1,11 | ||||
2025-06-05 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 10 125 | 69 225 | 17,13 | ||||
2024-07-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 677 | 132 756 | 3,65 | ||||
2024-06-10 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 624 | 59 356 | 1,06 | ||||
2024-06-10 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 9 863 | 58 732 | 20,18 | ||||
2024-05-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 000 | 128 079 | 14,28 | 35,53 | 568 480 | 4 550 647 | |
2023-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 112 079 | 5,00 | ||||
2023-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 777 | 106 746 | 1,69 | ||||
2023-06-08 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 576 | 48 869 | 1,19 | ||||
2023-06-08 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 7 290 | 48 293 | 17,78 | ||||
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 665 | 104 969 | 2,60 | ||||
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 102 304 | 5,50 | ||||
2022-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 201 | 41 003 | 0,49 | ||||
2022-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 4 907 | 40 802 | 13,67 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −1 778 | 9 775 | −15,39 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −666 | 11 553 | −5,45 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −889 | 12 219 | −6,78 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −5 333 | 13 108 | −28,92 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 778 | 96 971 | 1,87 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 666 | 95 193 | 0,70 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 94 527 | 0,95 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 93 638 | 6,04 | ||||
2021-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 5 333 | 18 441 | 40,69 | ||||
2021-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2021-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
M - Exercise | −6 366 | 0 | −100,00 | ||||
2021-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
A - Award | 4 907 | 4 907 | |||||
2021-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 6 366 | 35 895 | 21,56 | ||||
2020-09-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −11 250 | 0 | −100,00 | ||||
2020-09-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −11 250 | 0 | −100,00 | ||||
2020-09-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 11 250 | 88 305 | 14,60 | 28,47 | 320 288 | 2 514 043 | |
2020-09-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 11 250 | 77 055 | 17,10 | 12,94 | 145 575 | 997 092 | |
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 666 | −50,04 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 65 805 | 1,02 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −889 | 1 777 | −33,35 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 65 138 | 1,38 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 333 | 5 333 | |||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 778 | 5 332 | −25,01 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −666 | 0 | −100,00 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 778 | 64 249 | 2,85 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 666 | 62 471 | 1,08 | ||||
2020-06-10 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
M - Exercise | −4 610 | 0 | −100,00 | ||||
2020-06-10 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 312 | 29 529 | 1,07 | ||||
2020-06-10 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 4 610 | 29 217 | 18,73 | ||||
2020-06-10 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
A - Award | 6 366 | 6 366 | |||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 1 333 | −33,35 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 61 805 | 1,09 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −889 | 2 666 | −25,01 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 61 138 | 1,48 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 110 | 7 110 | |||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 666 | −50,04 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −666 | 0 | −100,00 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 60 249 | 1,12 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 666 | 59 582 | 1,13 | ||||
2019-06-11 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
M - Exercise | −6 018 | 4 610 | −56,62 | ||||
2019-06-11 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 254 | 24 607 | 1,04 | ||||
2019-06-11 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 6 018 | 24 353 | 32,82 | ||||
2019-06-11 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
A - Award | 4 610 | 10 628 | 76,60 | ||||
2019-03-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 58 916 | −14,51 | 79,63 | −796 258 | 4 691 234 | |
2018-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2018-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2018-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 000 | 68 916 | 27,82 | 9,30 | 139 500 | 640 919 | |
2018-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 000 | 53 916 | 38,54 | 9,22 | 138 300 | 497 106 | |
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 2 000 | −25,01 | ||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 38 916 | 1,74 | ||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 3 555 | 3 555 | |||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 000 | 1 999 | −50,01 | ||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 000 | 38 249 | 5,52 | ||||
2018-06-14 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
M - Exercise | −5 307 | 0 | −100,00 | ||||
2018-06-14 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 286 | 18 335 | 1,58 | ||||
2018-06-14 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 5 307 | 18 049 | 41,65 | ||||
2018-06-13 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
A - Award | 6 018 | 6 018 | |||||
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 590 | 36 249 | −19,16 | 45,03 | −386 808 | 1 632 292 | |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 590 | 44 839 | 23,70 | 13,88 | 119 229 | 622 365 | |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 010 | 36 249 | −14,22 | 45,79 | −275 198 | 1 659 842 | |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 010 | 42 259 | 16,58 | 13,88 | 83 419 | 586 555 | |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −400 | 36 249 | −1,09 | 44,02 | −17 608 | 1 595 681 | |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 400 | 36 649 | 1,10 | 13,88 | 5 552 | 508 688 | |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 469 | 3 999 | −38,17 | ||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 469 | 36 249 | 7,31 | ||||
2017-06-14 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
A - Award | 5 307 | 5 307 | |||||
2017-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
M - Exercise | −5 183 | 0 | −100,00 | ||||
2017-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 319 | 12 742 | 2,57 | ||||
2017-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 5 183 | 12 423 | 71,59 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −312 | 0 | −100,00 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 312 | 33 780 | 0,93 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 803 | 3 801 | −32,17 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 469 | 33 468 | 1,42 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 32 999 | 2,06 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 32 999 | 2,06 | ||||
2016-06-13 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
M - Exercise | −4 461 | 0 | −100,00 | ||||
2016-06-13 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
A - Award | 262 | 7 240 | 3,75 | ||||
2016-06-13 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 4 461 | 6 978 | 177,23 | ||||
2016-06-09 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
A - Award | 5 183 | 5 183 | |||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −312 | 312 | −50,00 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 312 | 31 665 | 1,00 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 2 000 | −25,01 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −469 | 937 | −33,36 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 31 353 | 2,17 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 469 | 30 686 | 1,55 | ||||
2015-06-11 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
A - Award | 4 461 | 4 461 | |||||
2015-04-03 |
|
4/A | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 2 438 | 2 517 | 3 086,08 | ||||
2015-03-31 |
|
4 | OUT |
OUTFRONT Media Inc.
Restricted Share Units |
M - Exercise | −2 438 | 0 | −100,00 | ||||
2015-03-31 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
F - Taxes | −913 | 1 604 | −36,27 | 30,09 | −27 472 | 48 264 | |
2015-03-31 |
|
4 | OUT |
OUTFRONT Media Inc.
Common Stock |
M - Exercise | 2 438 | 2 517 | 3 086,08 | ||||
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −12 500 | 0 | −100,00 | ||||
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 400 | 30 217 | −17,48 | 71,84 | −459 804 | 2 170 919 | |
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 400 | 36 617 | 21,18 | 5,93 | 37 952 | 217 139 | |
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 100 | 30 217 | −16,80 | 70,95 | −432 783 | 2 143 836 | |
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 100 | 36 317 | 20,19 | 5,93 | 36 173 | 215 360 | |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −12 500 | 0 | −100,00 | ||||
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −12 500 | 30 217 | −29,26 | 71,61 | −895 174 | 2 163 957 | |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 500 | 42 717 | 41,37 | 9,77 | 122 125 | 417 345 | |
2015-03-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −7 000 | 30 217 | −18,81 | 65,97 | −461 785 | 1 993 394 | |
2015-02-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2015-02-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 37 217 | −21,18 | 62,15 | −621 460 | 2 312 888 | |
2015-02-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 47 217 | 26,87 | 3,95 | 39 500 | 186 507 | |
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −313 | 624 | −33,40 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 313 | 37 217 | 0,85 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −469 | 1 406 | −25,01 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 469 | 36 904 | 1,29 | ||||
2014-04-01 |
|
4 | CBSO |
CBS OUTDOOR AMERICAS INC.
Restricted Share Units |
A - Award | 2 143 | 2 143 | |||||
2014-02-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −5 300 | 0 | −100,00 | ||||
2014-02-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 300 | 36 435 | 17,02 | 5,72 | 30 316 | 208 408 | |
2014-02-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −4 700 | 5 300 | −47,00 | ||||
2014-02-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 700 | 31 135 | −13,12 | 48,78 | −229 278 | 1 518 843 | |
2014-02-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 700 | 35 835 | 15,10 | 5,72 | 26 884 | 204 976 | |
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 31 135 | −24,31 | 50,98 | −509 803 | 1 587 272 | |
2013-12-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 41 135 | −19,56 | 40,01 | −400 125 | 1 645 914 | |
2013-12-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2013-12-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −9 731 | 51 135 | −15,99 | 39,13 | −380 813 | 2 001 117 | |
2013-12-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 000 | 60 866 | 32,70 | 16,32 | 244 800 | 993 333 | |
2013-11-27 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 45 866 | −17,90 | 36,63 | −366 336 | 1 680 237 | |
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −313 | 937 | −25,04 | ||||
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 313 | 55 866 | 0,56 | ||||
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 875 | 1 875 | |||||
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 11 250 | 11 250 | |||||
2013-06-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-06-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common stock |
S - Sale | −5 447 | 55 553 | −8,93 | 20,93 | −114 006 | 1 162 724 | |
2013-06-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 61 000 | 19,61 | 5,17 | 51 700 | 315 370 | |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 11 250 | 11 250 | |||||
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 250 | 1 250 | |||||
2012-06-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2012-06-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 51 000 | 24,39 | 8,15 | 81 500 | 415 650 | |
2005-07-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2004-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 |